SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-447915
Filing Date
2012-11-02
Accepted
2012-11-02 08:04:16
Documents
4
Period of Report
2012-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d432423d8k.htm 8-K 15917
2 PRESS RELEASE d432423dex991.htm EX-99.1 395869
3 GRAPHIC g432423image-oo1.jpg GRAPHIC 10302
4 GRAPHIC g432423image-oo2.jpg GRAPHIC 7395
  Complete submission text file 0001193125-12-447915.txt   437815
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 121175108
SIC: 2834 Pharmaceutical Preparations